2
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Breast Neoplasms
70
Prostatic Neoplasms
50
Multiple Myeloma
30
Neoplasm Metastasis
28
Osteoporosis
16
Pain
15
Carcinoma, Non-Small-Cell Lung
11
Neoplasms
10
Lung Neoplasms
8
Osteosarcoma
7
Neoplasms, Plasma Cell
7
Neuroblastoma
6
Carcinoma, Renal Cell
6
Bone Diseases, Metabolic
6
Humoral Hypercalcemia Of Malignancy
5
Bone Neoplasms
5
Fractures, Bone
4
Bone Diseases
4
Triple Negative Breast Neoplasms
3
Sarcoma, Ewing
3
Sarcoma
3
Lymphoma
3
Kidney Neoplasms
3
Uterine Cervical Neoplasms
2
Spinal Cord Compression
2
Small Cell Lung Carcinoma
2
Rhabdomyosarcoma
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Pleural Effusion, Malignant
2
Ovarian Neoplasms
2
Interventions
Zoledronic Acid
1
Exercise
1
Control Groups
1
Clodronic Acid
1
ARQ 197
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Osteolysis
×
Zoledronic Acid
×
Clear all
NCT02286830
2023-02-17
Magnolia
Odense University Hospital
Phase 4
Completed
158 enrolled